Glenmede Trust’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,541
Closed -$256K 1350
2022
Q3
$256K Buy
+3,541
New +$352K ﹤0.01% 1012
2020
Q4
Sell
-197
Closed -$16K 2334
2020
Q3
$16K Buy
197
+49
+33% +$4.14K ﹤0.01% 1705
2020
Q2
$10K Sell
148
-68
-31% -$4.62K ﹤0.01% 1886
2020
Q1
$12K Hold
216
﹤0.01% 2358
2019
Q4
$12K Buy
216
+66
+44% +$3.36K ﹤0.01% 2358
2019
Q3
$7K Hold
150
﹤0.01% 2526
2019
Q2
$8K Sell
150
-9
-6% -$412 ﹤0.01% 2483
2019
Q1
$6K Sell
159
-64
-29% -$2.5K ﹤0.01% 2572
2018
Q4
$6K Buy
+223
New +$8.6K ﹤0.01% 2491
2018
Q2
Sell
-72
Closed -$2K 2368
2018
Q1
$2K Hold
72
﹤0.01% 2617
2017
Q4
$2K Hold
72
﹤0.01% 2617
2017
Q3
$2K Hold
72
﹤0.01% 2604
2017
Q2
$2K Hold
72
﹤0.01% 2520
2017
Q1
$2K Hold
72
﹤0.01% 2520
2016
Q4
$1K Sell
72
-120
-63% -$2.97K ﹤0.01% 2428
2016
Q3
$4K Hold
192
﹤0.01% 2315
2016
Q2
$4K Buy
+192
New +$5.06K ﹤0.01% 2292

Other funds holding CTLT

Glenmede Trust's CTLT Position: Q4 2022 in Review

Glenmede Trust sold out of CATALENT, INC. (CTLT) in Q4 2022, closing a stake of 3,541 shares — an estimated $256K sold.

Glenmede Trust first reported a position in CTLT in Q2 2016 and held it in 17 quarters. The position peaked at $256K in Q3 2022. 485 funds tracked by Wall St. Rank hold CTLT as of Q4 2022.

  • Glenmede Trust reported no remaining CATALENT, INC. position as of Q4 2022 after selling out during the quarter.
  • Glenmede Trust sold 3,541 CATALENT, INC. shares in Q4 2022, an estimated $256K.
  • Glenmede Trust first reported a position in CATALENT, INC. in Q2 2016 and held it in 17 quarters.
  • Glenmede Trust's CATALENT, INC. position peaked at $256K in Q3 2022.
  • 485 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2022.

Based on Glenmede Trust's 13F filing for Q4 2022, filed 14 Feb 2023.